Newsroom

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Star Therapeutics, a late clinical-stage biotechnology company discovering and developing best-in-class antibodies for bleeding disorders and other diseases, today announced that Adam Rosenthal, Ph.D., CEO and Founder, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 4:30 p.m. PT in San Francisco, CA. Dr. Rosenthal will provide an overview of the company and its lead program, VGA039, a first-in-class...

NEWTON, Mass.--(BUSINESS WIRE)--Diversified Healthcare Trust (Nasdaq: DHC) (“DHC”) today provided a business update regarding its capital recycling program, the full repayment of its 2026 zero coupon bonds and the transition of operations of its senior housing operating portfolio (“SHOP”) communities from AlerisLife Inc. to new operators. Property Sales Update DHC continues to advance its previously disclosed capital recycling program focused on the sale of non-core properties. During the fourt...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma, Inc., a clinical-stage biopharmaceutical company pioneering next-generation targeted macrocycle therapeutics for cancer, today announced that David J. Earp, J.D., Ph.D., president and chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 5:00 p.m. PT. Dr. Earp will provide an overview of the company’s pipeline, including CID-078, a first-in-class oral macrocyclic c...

CHICAGO--(BUSINESS WIRE)--Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment insights, today announced that Anne Bramman has been elected to Morningstar’s board of directors. Bramman currently serves as a board director and audit committee chair at McCormick & Company and as a senior advisor at Boston Consulting Group. Prior to her current board and advisory roles, Bramman held senior leadership positions as CFO for several global companies including Nordstrom, A...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human genetics to develop first-in-class, next-generation medicines for cardioendocrine diseases, today announced that Josh Lehrer, M.D., chief executive officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026 at 10:30 a.m. PT. Dr. Lehrer will provide an overview of Marea’s pipeline, including MAR001 a fi...

LAKE MARY, Fla.--(BUSINESS WIRE)--VerifyMe and Token Economy Leader Open World Announce Plan for Strategic Merger...

CHARLOTTE, N.C.--(BUSINESS WIRE)--Dualboot Partners today launched DB90, an AI ecosystem for the full SDLC, including planning, design, development, testing, and deployment that increases productivity and delivers better software faster. DB90 blends top engineering talent with specialized AI agents that automate time-intensive work, reduce bottlenecks, and accelerate modernization and new product delivery. Early client programs have achieved up to 50% productivity gains for modernization effort...

FOSTER CITY, Calif.--(BUSINESS WIRE)--QuinStreet, Inc. (NASDAQ: QNST), a leader in performance marketplaces and technologies for the financial and home services industries, announced today that it has closed the acquisition of SIREN GROUP AG d/b/a HomeBuddy (“HomeBuddy”). Terms of the acquisition include $115 million in cash at closing and $75 million in post-closing payments payable equally over four years, subject to certain closing adjustments. QuinStreet further announced that it has entere...

No Headquarters/REDWOOD CITY, Calif.--(BUSINESS WIRE)--PubMatic, the leading AI-powered ad tech company delivering digital advertising performance, today announced the launch of PubMatic AgenticOS, an operating system designed to orchestrate autonomous, agent-to-agent advertising execution across premium digital environments. AgenticOS provides a system-level layer that allows agents to plan, transact, and optimize programmatic advertising with speed, consistency and control. PubMatic is launch...

TORONTO--(BUSINESS WIRE)--Subway Canada donne le coup d’envoi de l’année 2026 avec des nouveautés qui suscitent l’envie. Dites bonjour au menu Frais et actif : cinq délicieux sandwichs contenant plus de 21 g de protéines et moins de 500 calories chacun. Ils sont fraîchement préparés, audacieux et conçus pour les Canadiens qui veulent combiner le bon goût à leurs objectifs. Offert dès maintenant partout au pays, le menu Frais et actif met de l’avant des sandwichs signatures, conçus avec des opti...